These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10197049)

  • 1. Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases.
    Mollison KW; Fey TA; Gauvin DM; Sheets MP; Smith ML; Pong M; Krause R; Miller L; Or YS; Kawai M; Wagner R; Wiedeman PE; Clark RF; Gunawardana IW; Rhoades TA; Henry CL; Tu NP; BaMaung NY; Kopecka H; Liu L; Xie Q; Lane BC; Trevillyan JM; Marsh K; Luly JR
    Curr Pharm Des; 1998 Oct; 4(5):367-79. PubMed ID: 10197049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A macrolactam inhibitor of T helper type 1 and T helper type 2 cytokine biosynthesis for topical treatment of inflammatory skin diseases.
    Mollison KW; Fey TA; Gauvin DM; Kolano RM; Sheets MP; Smith ML; Pong M; Nikolaidis NM; Lane BC; Trevillyan JM; Cannon J; Marsh K; Carter GW; Or YS; Chen YW; Hsieh GC; Luly JR
    J Invest Dermatol; 1999 May; 112(5):729-38. PubMed ID: 10233764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolactam immunomodulators for topical treatment of inflammatory skin diseases.
    Bornhövd E; Burgdorf WH; Wollenberg A
    J Am Acad Dermatol; 2001 Nov; 45(5):736-43. PubMed ID: 11606925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
    Grassberger M; Steinhoff M; Schneider D; Luger TA
    Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ascomycins in dermatology.
    Paul C; Ho VC
    Semin Cutan Med Surg; 1998 Dec; 17(4):256-9. PubMed ID: 9859912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical FK506--clinical potential or laboratory curiosity?
    Lauerma AI; Maibach HI
    Dermatology; 1994; 188(3):173-6. PubMed ID: 7514460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical tacrolimus for the treatment of inflammatory skin diseases.
    Assmann T; Homey B; Ruzicka T
    Expert Opin Pharmacother; 2001 Jul; 2(7):1167-75. PubMed ID: 11583067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.
    Stuetz A; Baumann K; Grassberger M; Wolff K; Meingassner JG
    Int Arch Allergy Immunol; 2006; 141(3):199-212. PubMed ID: 16926539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascomycins: promising agents for the treatment of inflammatory skin diseases.
    Paul C; Graeber M; Stuetz A
    Expert Opin Investig Drugs; 2000 Jan; 9(1):69-77. PubMed ID: 11060661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical tacrolimus in the treatment of atopic dermatitis.
    Gianni LM; Sulli MM
    Ann Pharmacother; 2001; 35(7-8):943-6. PubMed ID: 11485148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pimecrolimus cream 1%: a new development in nonsteroid topical treatment of inflammatory skin diseases.
    Hebert AA; Warken KA; Cherill R
    Semin Cutan Med Surg; 2001 Dec; 20(4):260-7. PubMed ID: 11770913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development and pre-clinical aspects of pimecrolimus].
    Stütz A; Grassberger M; Meingassner JG
    Hautarzt; 2003 May; 54(5):405-12. PubMed ID: 12719859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity.
    Stuetz A; Grassberger M; Meingassner JG
    Semin Cutan Med Surg; 2001 Dec; 20(4):233-41. PubMed ID: 11770910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pimecrolimus--a safe and effective local immunomodulator in the treatment of inflammatory skin diseases.
    Lipozencić J
    Acta Dermatovenerol Croat; 2005; 13(1):63-9. PubMed ID: 15788149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical pimecrolimus for skin disease other than atopic dermatitis.
    Wollina U; Hansel G; Koch A; Abdel-Naser MB
    Expert Opin Pharmacother; 2006 Oct; 7(14):1967-75. PubMed ID: 17020422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology.
    Meingassner JG; Grassberger M; Fahrngruber H; Moore HD; Schuurman H; Stütz A
    Br J Dermatol; 1997 Oct; 137(4):568-76. PubMed ID: 9390333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive macrolides and their use in dermatology].
    Bornhövd EC; Schuller E; Bieber T; Wollenberg A
    Hautarzt; 2000 Sep; 51(9):646-54. PubMed ID: 11057390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pimecrolimus in dermatology.
    Fabroni C; Lotti T
    G Ital Dermatol Venereol; 2009 Jun; 144(3):321-5. PubMed ID: 19528913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide immunosuppressants.
    Mrowietz U
    Eur J Dermatol; 1999; 9(5):346-51. PubMed ID: 10417434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.